Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
Portfolio Pulse from
Thermo Fisher Scientific reported its Q4 and full year 2024 financial results. Q4 revenue increased by 5% to $11.40 billion, with GAAP EPS up 14% to $4.78 and adjusted EPS up 8% to $6.10. Full year revenue remained flat at $42.88 billion.
January 30, 2025 | 11:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Thermo Fisher Scientific's Q4 2024 results show a 5% revenue increase to $11.40 billion and a 14% rise in GAAP EPS to $4.78. Adjusted EPS grew 8% to $6.10. Full year revenue was flat at $42.88 billion.
The positive growth in Q4 revenue and EPS suggests strong performance, likely boosting investor confidence. However, the flat full year revenue may temper enthusiasm slightly. Overall, the short-term impact on TMO's stock price is likely positive.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100